Literature DB >> 24319112

Novel paradigms for dialysis vascular access: Introduction.

Michael Allon1.   

Abstract

Mesh:

Year:  2013        PMID: 24319112      PMCID: PMC3848401          DOI: 10.2215/CJN.03650413

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  33 in total

1.  Salvage of immature forearm fistulas for haemodialysis by interventional radiology.

Authors:  L Turmel-Rodrigues; A Mouton; B Birmelé; L Billaux; N Ammar; O Grézard; S Hauss; J Pengloan
Journal:  Nephrol Dial Transplant       Date:  2001-12       Impact factor: 5.992

2.  Highly increased cell proliferation activity in the restenotic hemodialysis vascular access after percutaneous transluminal angioplasty: implication in prevention of restenosis.

Authors:  Chi-Jen Chang; Po-Jen Ko; Lung-An Hsu; Yu-Shien Ko; Yu-Lin Ko; Chin-Fen Chen; Chiu-Ching Huang; Tsu-Shiu Hsu; Ying-Shiung Lee; Jong-Hwei S Pang
Journal:  Am J Kidney Dis       Date:  2004-01       Impact factor: 8.860

3.  Length polymorphism in heme oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients.

Authors:  C-C Lin; W-C Yang; S-J Lin; T-W Chen; W-S Lee; C-F Chang; P-C Lee; S-D Lee; T-S Su; C S-J Fann; M-Y Chung
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

Review 4.  Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint.

Authors:  Prabir Roy-Chaudhury; Vikas P Sukhatme; Alfred K Cheung
Journal:  J Am Soc Nephrol       Date:  2006-04       Impact factor: 10.121

5.  Correlation of pre-existing vascular pathology with arteriovenous graft outcomes in hemodialysis patients.

Authors:  Michael Allon; Silvio Litovsky; Carlton J Young; Mark H Deierhoi; Jeremy Goodman; Michael Hanaway; Mark E Lockhart; Michelle L Robbin
Journal:  Am J Kidney Dis       Date:  2013-06-05       Impact factor: 8.860

6.  Characterization of neointima lesions associated with arteriovenous fistulas in a mouse model.

Authors:  Y Castier; S Lehoux; Y Hu; G Foteinos; G Fonteinos; A Tedgui; Q Xu
Journal:  Kidney Int       Date:  2006-06-07       Impact factor: 10.612

7.  Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis.

Authors:  James S Kaufman; Theresa Z O'Connor; Jane Hongyuan Zhang; Robert E Cronin; Louis D Fiore; Michael B Ganz; David S Goldfarb; Peter N Peduzzi
Journal:  J Am Soc Nephrol       Date:  2003-09       Impact factor: 10.121

8.  Aggressive treatment of early fistula failure.

Authors:  Gerald A Beathard; Perry Arnold; Jerry Jackson; Terry Litchfield
Journal:  Kidney Int       Date:  2003-10       Impact factor: 10.612

9.  Preexisting intimal hyperplasia of radial artery is associated with early failure of radiocephalic arteriovenous fistula in hemodialysis patients.

Authors:  Young Ok Kim; Ho Cheol Song; Sun Ae Yoon; Chul Woo Yang; Nam Il Kim; Yeong Jin Choi; Eun Jung Lee; Wan Young Kim; Yoon Sik Chang; Byung Kee Bang
Journal:  Am J Kidney Dis       Date:  2003-02       Impact factor: 8.860

10.  Percutaneous management of perianastomotic stenosis in arteriovenous fistulae: results of a prospective study.

Authors:  A Asif; O Lenz; D Merrill; G Cherla; C D Cipleu; R Ellis; B Francois; D L Epstein; P Pennell
Journal:  Kidney Int       Date:  2006-05       Impact factor: 10.612

View more
  2 in total

1.  Preoperative arterial microcalcification and clinical outcomes of arteriovenous fistulas for hemodialysis.

Authors:  Michael Allon; Michelle L Robbin; Heidi R Umphrey; Carlton J Young; Mark H Deierhoi; Jeremy Goodman; Michael Hanaway; Mark E Lockhart; Jill Barker-Finkel; Silvio Litovsky
Journal:  Am J Kidney Dis       Date:  2015-02-18       Impact factor: 8.860

2.  Preoperative Vascular Medial Fibrosis and Arteriovenous Fistula Development.

Authors:  Yan-Ting Shiu; Silvio H Litovsky; Alfred K Cheung; Daniel B Pike; Jason Chieh Sheng Tey; Yingying Zhang; Carlton J Young; Michelle Robbin; Kenneth Hoyt; Michael Allon
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-30       Impact factor: 8.237

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.